Understand the source comparison
SS-LUP-332 Dosage Protocol: Research Methods Comparison
Research teams structure SS-LUP-332 protocols differently depending on study objectives. Acute metabolic challenge vs chronic adaptation, body composition outcomes vs mitochondrial enzyme expression, rodent models vs in vitro cell culture. The table below maps
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research teams structure SS-LUP-332 protocols differently depending on study objectives. Acute metabolic challenge vs chronic adaptation, body composition outcomes vs mitochondrial enzyme expression, rodent models vs in vitro cell culture. The table below maps dosing parameters to common research applications.
- Baseline Metabolic Shift
- 10mg daily
- Subcutaneous
- Once daily (same time ±30min)
- 21–28 days
- Oxygen consumption (VO2), respiratory exchange ratio, fatty acid oxidation rates
- Standard protocol for measuring sustained metabolic adaptation. Produces consistent ERRα activation without confounding appetite suppression
- Dose-Response Curve
- 5mg, 10mg, 15mg, 20mg, 25mg
- Once daily
- 14 days per dose
- Mitochondrial enzyme expression (COX-IV, citrate synthase), PGC-1α mRNA levels
- Essential for establishing therapeutic window in new models. Reveals the dose at which efficacy plateaus and adverse events begin
- Acute Metabolic Challenge
- 15–20mg single dose
- Intraperitoneal
- Single administration
- 6–12 hours
- Peak plasma glucose clearance, insulin sensitivity index, hepatic glucose output
- Preferred for mechanistic studies isolating ERRα receptor activation from chronic metabolic adaptation
- Body Composition Study
- 15mg daily
- 42–56 days
- Lean mass gain, fat mass reduction (DEXA or MRI), daily food intake
- Requires longer duration because body composition changes lag behind metabolic enzyme upregulation by 2–3 weeks
- In Vitro Cell Culture
- 1–10 μM (culture medium)
- Direct addition to medium
- Single treatment or daily renewal
- 24–72 hours
- Mitochondrial respiration (Seahorse assay), lipid droplet accumulation, gene expression
- Concentration range 100× lower than in vivo doses due to direct cellular exposure without pharmacokinetic dilution